Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q69ZN7

Entry ID Method Resolution Chain Position Source
AF-Q69ZN7-F1 Predicted AlphaFoldDB

124 variants for Q69ZN7

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3408830207 35 T>R No EVA
rs46477910 65 L>M No EVA
rs37575356 66 V>A No EVA
rs3389516408 77 Q>R No EVA
rs3389541968 78 N>K No EVA
rs3389542010 81 I>F No EVA
rs31052565 92 I>T No EVA
rs3389547220 95 Q>H No EVA
rs3389516410 103 Q>P No EVA
rs256045155 104 T>N No EVA
rs3389530857 115 G>R No EVA
rs3389539206 115 G>V No EVA
rs3389445374 131 H>Y No EVA
rs241883672 135 P>L No EVA
rs237136106 187 S>N No EVA
rs3389553116 188 S>I No EVA
rs3389547233 207 E>G No EVA
rs3389530866 222 V>L No EVA
rs3410966590 237 N>S No EVA
rs3389536664 255 E>K No EVA
rs3389502511 271 L>* No EVA
rs3389539164 274 D>V No EVA
rs3389553117 291 P>S No EVA
rs3389539189 292 G>D No EVA
rs3389516378 312 A>T No EVA
rs3389445401 329 P>L No EVA
rs3389538333 335 D>E No EVA
rs3389553044 348 L>* No EVA
rs3389492336 348 L>I No EVA
rs3389538305 386 G>D No EVA
rs3389539236 442 V>I No EVA
rs3389539239 457 T>M No EVA
rs3389530879 465 A>T No EVA
rs3389532201 476 G>V No EVA
rs3389542011 477 E>V No EVA
rs3389542007 478 T>R No EVA
rs3389516351 479 E>D No EVA
rs3389530915 479 E>G No EVA
rs3389537783 506 P>L No EVA
rs3389445335 520 Y>C No EVA
rs3389547247 525 F>L No EVA
rs3389516365 540 K>N No EVA
rs3407224802 566 V>L No EVA
rs1131991174 581 Q>E No EVA
rs3412162618 585 S>C No EVA
rs1133009192 586 I>M No EVA
rs1135220865 586 I>S No EVA
rs3389548443 587 G>A No EVA
rs3389542030 602 S>T No EVA
rs3389537693 603 T>I No EVA
rs3389502576 620 P>L No EVA
rs3389532221 644 V>M No EVA
rs3389530894 680 K>E No EVA
rs3389538331 712 L>* No EVA
rs3389553109 713 R>G No EVA
rs3389547227 715 R>W No EVA
rs3389536619 735 K>T No EVA
rs3389548437 772 R>G No EVA
rs3389547248 838 S>I No EVA
rs3389516379 853 N>K No EVA
rs225287483 897 D>E No EVA
rs3389547209 1006 R>M No EVA
rs228908959 1010 L>M No EVA
rs260388462 1021 T>M No EVA
rs3389537742 1025 T>I No EVA
rs3389516396 1027 R>G No EVA
rs3389492280 1031 E>D No EVA
rs3389492362 1054 S>R No EVA
rs3389538274 1085 L>R No EVA
rs38359395 1094 E>D No EVA
rs3409122904 1111 A>P No EVA
rs1133619657 1118 C>* No EVA
rs3389547249 1127 H>Q No EVA
rs3389530878 1176 T>I No EVA
rs3409313346 1187 E>D No EVA
rs3409206460 1187 E>V No EVA
rs3389538334 1226 N>Y No EVA
rs3389532261 1235 L>I No EVA
rs3408509262 1261 K>R No EVA
rs3389536678 1279 M>V No EVA
rs3389532217 1294 E>K No EVA
rs3389529628 1329 V>M No EVA
rs3389536633 1332 S>G No EVA
rs3389530869 1343 V>L No EVA
rs228166463 1357 M>I No EVA
rs265381722 1357 M>T No EVA
rs3409037320 1363 K>N No EVA
rs3409122918 1364 V>D No EVA
rs3389536677 1383 H>R No EVA
rs3389541969 1384 L>V No EVA
rs3389516348 1385 D>* No EVA
rs37181646 1388 R>W No EVA
rs3389492311 1401 Q>* No EVA
rs3389532259 1406 L>M No EVA
rs3389548400 1413 R>Q No EVA
rs3389536656 1413 R>W No EVA
rs3389553086 1460 K>N No EVA
rs233419927 1521 S>G No EVA
rs3408166537 1534 D>G No EVA
rs3389492326 1548 Q>R No EVA
rs3389548459 1551 Q>E No EVA
rs3389537746 1573 V>E No EVA
rs3389484791 1618 D>G* No EVA
rs3389553099 1656 D>V No EVA
rs3389548381 1701 K>T No EVA
rs3389492367 1719 L>P No EVA
rs3389529651 1731 T>I No EVA
rs3389547274 1737 T>S No EVA
rs3389536673 1747 L>H No EVA
rs3389532224 1771 K>I No EVA
rs37220677 1783 N>D No EVA
rs3389536653 1795 T>A No EVA
rs3389537720 1802 I>N No EVA
rs3389529596 1851 A>T No EVA
rs3389537748 1862 T>K No EVA
rs3389532256 1894 H>L No EVA
rs3389492305 1898 I>V No EVA
rs3389502549 1901 K>T No EVA
rs3389484768 1917 M>L No EVA
rs37096150 1946 T>A No EVA
rs3408089514 1947 R>W No EVA
rs3389542044 2014 V>A No EVA
rs3389445367 2022 L>F No EVA
rs252193461 2023 I>V No EVA

No associated diseases with Q69ZN7

21 regional properties for Q69ZN7

Type Name Position InterPro Accession
domain C2 domain 1 - 101 IPR000008-1
domain C2 domain 183 - 300 IPR000008-2
domain C2 domain 339 - 475 IPR000008-3
domain C2 domain 1110 - 1238 IPR000008-4
domain C2 domain 1269 - 1397 IPR000008-5
domain C2 domain 1523 - 1641 IPR000008-6
domain C2 domain 1759 - 1907 IPR000008-7
domain Peroxin/Ferlin domain 843 - 901 IPR006614-1
domain Peroxin/Ferlin domain 914 - 970 IPR006614-2
domain Peroxin/Ferlin domain 979 - 1017 IPR006614-3
domain Peroxin/Ferlin domain 1037 - 1070 IPR006614-4
domain Ferlin A-domain 663 - 728 IPR012560
domain Ferlin B-domain 755 - 829 IPR012561
domain FerIin domain 282 - 353 IPR012968
domain Ferlin, C-terminal domain 1946 - 2043 IPR032362
domain Ferlin, second C2 domain 196 - 305 IPR037720
domain Ferlin, third C2 domain 359 - 522 IPR037722
domain Ferlin, fourth C2 domain 1126 - 1259 IPR037723
domain Ferlin, fifth C2 domain 1541 - 1664 IPR037724
domain Ferlin, sixth C2 domain 1777 - 1908 IPR037725
domain Ferlin, first C2 domain 5 - 136 IPR037726

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Single-pass type II membrane protein
  • Nucleus membrane ; Single-pass type II membrane protein
  • Cytoplasmic vesicle membrane ; Single-pass type II membrane protein
  • Found at nuclear and plasma membranes
  • Enriched in undifferentiated myoblasts near the plasma membrane in puncate structures (By similarity)
  • Concentrated at the membrane sites of both myoblast-myoblast and myoblast-myotube fusions
  • Detected at the plasmalemma in endothelial cells lining intact blood vessels
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
caveola A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
cytoplasmic vesicle A vesicle found in the cytoplasm of a cell.
cytoplasmic vesicle membrane The lipid bilayer surrounding a cytoplasmic vesicle.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
nuclear membrane Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

2 GO annotations of molecular function

Name Definition
metal ion binding Binding to a metal ion.
phospholipid binding Binding to a phospholipid, a class of lipids containing phosphoric acid as a mono- or diester.

9 GO annotations of biological process

Name Definition
cellular response to heat Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
glycerol metabolic process The chemical reactions and pathways involving glycerol, 1,2,3-propanetriol, a sweet, hygroscopic, viscous liquid, widely distributed in nature as a constituent of many lipids.
membrane fusion The membrane organization process that joins two lipid bilayers to form a single membrane.
muscle cell development The process whose specific outcome is the progression of a muscle cell over time, from its formation to the mature structure. Muscle cell development does not include the steps involved in committing an unspecified cell to the muscle cell fate.
myoblast fusion A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
plasma membrane organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the plasma membrane.
plasma membrane repair The resealing of a cell plasma membrane after cellular wounding due to, for instance, mechanical stress.
regulation of vascular endothelial growth factor receptor signaling pathway Any process that modulates the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
T-tubule organization A process that is carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of the T-tubule. A T-tubule is an invagination of the plasma membrane of a muscle cell that extends inward from the cell surface around each myofibril.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9NZM1 MYOF Myoferlin Homo sapiens (Human) PR
10 20 30 40 50 60
MLRVIVESAT NIPKTKFGKP DPIVSVIFKD EKKKTKKVDN ELNPVWNEIL EFDLRGIPLD
70 80 90 100 110 120
SSSSLVIVVK DFETIGQNKL IGTATVSLKD LIGDQNRSLP YKQTSLLNEK GQDTGATIDL
130 140 150 160 170 180
VIGYTPPSAP HPNDPSGTSV PGMGEEEEED QGDEDRVDGI VRGPGPKGPS GTVSEAQLAR
190 200 210 220 230 240
RITKGKSSRR MLSNKPQDFQ IRVRVIEGRQ LCGNNIRPVV KVHICGQTHR TRIKRGNNPF
250 260 270 280 290 300
FDELFFYNVH ITPSELMDEI ISIRVYNSHS LRADCLMGEF KIDVGFVYDE PGHAVMRKWL
310 320 330 340 350 360
LLNDPEDTSS GAKGYMKVSM FVLGTGDEPP PEKRDRDNDS DDVESNLLLP AGIALRWVTF
370 380 390 400 410 420
MLKIYRAEDI PQMDDAFSQT VKEIFGGNAD KKNLVDPFVE VSFAGKKVCT NIIERNANPE
430 440 450 460 470 480
WNQVVNLQIK FPSMCEKIKL TVYDWDRLTK NDVVGTTYLY LSKIAASGGE VEATTGETEV
490 500 510 520 530 540
GFVPTFGPCY LNLYGSPREY TGFPDPYDEL NSGKGEGVAY RGRIFVELNT FLEKKPPEKK
550 560 570 580 590 600
LEPISSDDLL VVEKYQRRRK YSLSAVFHSA TMLQDVGEAI QFEVSIGNYG NKFDATCKPL
610 620 630 640 650 660
ASTTQYSRAV FDGNYYYYLP WAHTKPVVTL TSYWEDISHR LDAVNTLLVM AERLQSNIEA
670 680 690 700 710 720
VKSGIQGKIP ANQLAEVWLK LIDEVIEDTR YTLPVTEGKA NVTVLDTQIR KLRSRFLSQI
730 740 750 760 770 780
HEAALRMRSE ATDVKSTLLE IEEWLDKLMQ LTEEPQNSMP DIIIWMIRGE KRLAYARIPA
790 800 810 820 830 840
HQVLYSTSGG NASGKYCGKT QTILLKYPQE KTNGPKVPVE LRVNIWLGLS AVEKKFNSFA
850 860 870 880 890 900
EGTFTVFAEM YENQALVFGK WGTSGLVGRH KFSDVTGKIK LKREFFLPPK GWEWEGDWVV
910 920 930 940 950 960
DPERSLLTEA DAGHTEFTDE VYQNENRYPG GEWKQAEDTY TDANGDKAAS PSEMTCPPGW
970 980 990 1000 1010 1020
EWEDDAWIYD INRAVDEKGW EYGITIPPDN KPKSWVAAEK MYHTHRRRRL VRKRKKDLTQ
1030 1040 1050 1060 1070 1080
TASSTARAME ELEDREGWEY ASLIGWKFHW KQRSSDTFRR RRWRRKMAPS ETHGAAAIFK
1090 1100 1110 1120 1130 1140
LEGALGADTT EDGEEKGPEK QKHSATTVFG ANTPIVSCNF DRVYIYHLRC YIYQARNLMA
1150 1160 1170 1180 1190 1200
LDKDSFSDPY AHVSFLHRSK TTEIIHSTLN PTWDQTIIFD EVEIFGEPQT VLQNPPNVTI
1210 1220 1230 1240 1250 1260
ELFDNDQVGK DEFLGRSICS PLVKLNSETD ITPKLLWHPV MNGDKACGDV LVTAELILRN
1270 1280 1290 1300 1310 1320
KDGSNLPILP SQRAPNLYMV PQGIRPVVQL TAIEILAWGL RNMKNYQMAS VTSPSLVVEC
1330 1340 1350 1360 1370 1380
GGERVESVVI KSLKKTPNFP SSVLFMKVFL PKEELYMPPL VIKVIDHRQF GRKPVVGQCT
1390 1400 1410 1420 1430 1440
IDHLDRFRCD PYAGKEDIVP QLKASLMSAP PCREVVIEIE DTKPLLASKL SEKEEEIVDW
1450 1460 1470 1480 1490 1500
WSKFYASSGE HEKCGQYIQK GYSKLKIYDC ELEDVADFEG LTDFSDTFKL YRGKSDENED
1510 1520 1530 1540 1550 1560
PSVVGEFKGS FRIYPLPDDP SVPAPPRQFR ELPDSVPQEC TVRIYIVQGL QLQPQDNNGL
1570 1580 1590 1600 1610 1620
CDPYIKITLG KKVIEDRDHY IPNTLNPVFG RMYELSCYLP QEKDLKISVY DYDTFTRDEK
1630 1640 1650 1660 1670 1680
VGETTIDLEN RFLSRFGSHC GIPEQYCVSG VNTWRDQLRP TQLLQNVARF KGFPPPVLSE
1690 1700 1710 1720 1730 1740
DGSRIRYGGR DYHLDEFEAN KILHQHLGAP EERLALHILR TQGLVPEHVE TRTLHSTFQP
1750 1760 1770 1780 1790 1800
NISQGKLQMW VDVFPKSLGP PGPPFNITPR KAKKYYLRVI IWNTKDVILD EKSITGEDMS
1810 1820 1830 1840 1850 1860
DIYVKGWISG SEENKQKTDV HYRSLDGEGN FNWRFVFPFD YLPAEQLCIV AKKEHFWSID
1870 1880 1890 1900 1910 1920
QTEFRVPPRL IIQIWDNDKF SLDDYLGFLE LDLHRTIIPA KTSEKCSLDM IPDLKAMDPL
1930 1940 1950 1960 1970 1980
KAKTASLFEQ RSMKGWWPCY ADKDGTRVMA GKVEMTLEVL NEREADERPA GKGRSEPNMN
1990 2000 2010 2020 2030 2040
PKLDPPNRPE TSFLWFTNPC KTMRFIVWRR FKWVIIGLLL LLILLLFVAV LLYSLPNYLS
MKIVRPNA